clemastine has been researched along with Hypoxia-Ischemia, Brain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernis, ME; Imam, FB; Maes, E; Maltepe, E; Pang, R; Pasca, AM; Robertson, NJ; Sabir, H; Schleehuber, Y; Silverman, J; White, Y; Zweyer, M | 1 |
| Gao, C; Ge, X; Ma, Y; Pan, S; Tang, J; Wang, Y; Xie, D; Zhu, Y | 1 |
2 other study(ies) available for clemastine and Hypoxia-Ischemia, Brain
| Article | Year |
|---|---|
Comparing the efficacy in reducing brain injury of different neuroprotective agents following neonatal hypoxia-ischemia in newborn rats: a multi-drug randomized controlled screening trial.
Topics: Allopurinol; Animals; Animals, Newborn; Asphyxia Neonatorum; Brain; Brain Injuries; Caffeine; Clemastine; Disease Models, Animal; Hedgehog Proteins; Humans; Hydroxybutyrates; Hypothermia, Induced; Hypoxia; Hypoxia-Ischemia, Brain; Infant, Newborn; Ischemia; Melatonin; Neuroprotective Agents; Rats | 2023 |
Clemastine improves hypomyelination in rats with hypoxic-ischemic brain injury by reducing microglia-derived IL-1β via P38 signaling pathway.
Topics: Animals; Clemastine; Demyelinating Diseases; Histamine H1 Antagonists; Hypoxia-Ischemia, Brain; Interleukin-1beta; Male; Microglia; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Signal Transduction | 2020 |